University of Notre Dame du Lac’s Ascendis Pharma A/S ASND Stock Holding History

University of Notre Dame du Lac’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,787	Closed	-$877K	–	34
2020 Q1	$877K	Sell	7,787 -776	-9%	-$101K	0.27%	47
2019 Q4	$1.19M	Buy	8,563 +809	+10%	+$89.9K	0.38%	37
2019 Q3	$747K	Sell	7,754 -22,380	-74%	-$2.5M	0.22%	53
2019 Q2	$3.47M	Sell	30,134 -6,479	-18%	-$775K	0.79%	52
2019 Q1	$4.31M	Sell	36,613 -2,904	-7%	-$254K	0.96%	40
2018 Q4	$2.48M	Sell	39,517 -1,354	-3%	-$85.1K	0.6%	50
2018 Q3	$2.9M	Sell	40,871 -1,309	-3%	-$90.1K	0.54%	54
2018 Q2	$2.81M	Sell	42,180 -5,817	-12%	-$383K	0.54%	56
2018 Q1	$3.14M	Sell	47,997 -25,774	-35%	-$1.45M	0.58%	57
2017 Q4	$2.96M	Buy	+73,771	New	+$2.68M	0.61%	54

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

University of Notre Dame du Lac's ASND Position: Q2 2020 in Review

University of Notre Dame du Lac sold out of Ascendis Pharma A/S (ASND) in Q2 2020, closing a stake of 7,787 shares — an estimated $877K sold.

University of Notre Dame du Lac first reported a position in ASND in Q4 2017 and held it in 10 quarters. The position peaked at $4.31M in Q1 2019. 154 funds tracked by Wall St. Rank hold ASND as of Q2 2020.

University of Notre Dame du Lac reported no remaining Ascendis Pharma A/S position as of Q2 2020 after selling out during the quarter.
University of Notre Dame du Lac sold 7,787 Ascendis Pharma A/S shares in Q2 2020, an estimated $877K.
University of Notre Dame du Lac first reported a position in Ascendis Pharma A/S in Q4 2017 and held it in 10 quarters.
University of Notre Dame du Lac's Ascendis Pharma A/S position peaked at $4.31M in Q1 2019.
154 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2020.

Based on University of Notre Dame du Lac's 13F filing for Q2 2020, filed 14 Aug 2020.